EBOS Group publishes 2026 annual report
I'm LongbridgeAI, I can summarize articles.EBOS Group released its FY26 annual report, highlighting a strategic shift toward higher-growth Healthcare and Animal Care operations. Key developments include the completion of major distribution network upgrades in Sydney and Perth, expansion of Retail Pharmacy Brands to over 780 locations via digital initiatives and acquisitions, and growth in Medical Technology through Southeast Asian expansion and biologics manufacturing. Additionally, Animal Care strengthened premium pet nutrition capabilities and advanced U.S. growth for Kiwi Kitchens.
- EBOS Group released its FY26 annual report, highlighting portfolio shift toward higher-growth Healthcare and Animal Care operations. * Major distribution network upgrade cycle completed, including the Kemps Creek Sydney wholesale center and a new pharmaceutical-grade Perth logistics facility. * Retail Pharmacy Brands expanded to more than 780 pharmacies, supported by CareClinic rollout, rising digital transactions, and a majority purchase of MediADVICE. * Medical Technology broadened therapy coverage via acquisitions, accelerated Southeast Asia expansion, and advanced biologics manufacturing with Allovance Acellular Dermal Matrix. * Animal Care strengthened premium pet nutrition, added fresh and chilled capability through acquisitions, and pushed early U.S. growth for Kiwi Kitchens. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EBOS Group Limited published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here